Cargando…
A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing
Genetic factors have long been recognized as important determinants of interindividual variability in drug efficacy and toxicity. However, despite the increasing number of established gene–drug associations, candidate polymorphisms can only explain a fraction of the genetically encoded functional va...
Autores principales: | Zhou, Yitian, Koutsilieri, Stefania, Eliasson, Erik, Lauschke, Volker M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805052/ https://www.ncbi.nlm.nih.gov/pubmed/35971800 http://dx.doi.org/10.1111/bcpt.13779 |
Ejemplares similares
-
Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
por: Hiratsuka, Masahiro, et al.
Publicado: (2021) -
Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health
por: Zhou, Yitian, et al.
Publicado: (2021) -
Pharmacogenomic network analysis of the gene-drug interaction landscape underlying drug disposition
por: Zhou, Yitian, et al.
Publicado: (2019) -
Structural variation of the coding and non-coding human pharmacogenome
por: Tremmel, Roman, et al.
Publicado: (2023) -
Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences
por: Zhou, Yitian, et al.
Publicado: (2023)